Fierce Pharma
AUGUST 23, 2024
Bayer’s latest round of layoffs has reportedly hit Basel, Switzerland, home of the international headquarters of the company's consumer health division. | The layoffs are the latest in Bayer's massive restructuring plan that has so far impacted more than 3,000 staffers since the start of the year.
MedCity News
AUGUST 23, 2024
AI startup Paige launched an AI-powered biomarker module that the company says can evaluate more than 505 genes and identify 1,228 molecular biomarkers from standard pathology slides. The post Paige Launches AI Tool that Screens 505 Genes for Improved Cancer Diagnosis appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
AUGUST 23, 2024
The FDA has authorized the use of | The FDA has authorized the use of new vaccines from Pfizer/BioNTech and Moderna which have been designed to defend against the Omicron KP.2 variant of SARS-CoV-2. The nod comes as word of a new omicron variant, KP.3.1.1, is beginning to eclipse KP.2 as the dominant strain of the virus in the United States.
MedCity News
AUGUST 23, 2024
Healthcare is a highly regulated industry, and any use of AI within it is dealing with the most sensitive data. In order to ensure you’re not putting you, your company or patients at risk, consider an evaluation framework for any AI tool that considers these three things. The post From FOMO to FOMU: A Framework for Getting AI Right appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
AUGUST 23, 2024
While some analysts figure Jazz Pharmaceuticals’ Epidiolex—sold as Epidyolex abroad—could surpass the blockbuster sales threshold by the end of the decade, the cannabidiol-based seizure drug has st | On Friday, Jazz revealed that its Epidiolex oral solution failed to mass muster in a late-stage study when used as an adjunct treatment for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS) or tuberous sclerosis complex (TSC) in young Japanese patients.
MedCity News
AUGUST 23, 2024
Celeste Health Solutions launched on Wednesday. The company works with employers and offers a range of point solutions and provides administrative support. The post How One Company Is Easing Employers’ Administrative Headaches appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 23, 2024
Digital tools are producing a more efficient patient-centered system. Practices tuned in to the new digital world operate more smoothly, deliver higher-quality care, and allow payers to manage costs and risks more effectively. The post Time to Get Digital in Your Practice: Improving and Making Healthcare Easier for Patients, Practices, Providers and Payors appeared first on MedCity News.
Fierce Pharma
AUGUST 23, 2024
Yuhan's Lazcluze, licensed by Johnson & Johnson, has made history as the first Korea-developed novel cancer drug to be approved by the FDA. | As part of a J&J combo, Yuhan's Lazcluze has become the first Korea-developed novel cancer drug to be approved by the FDA. Merck has optioned in on one Kelun Biotech ADC but returned another.
pharmaphorum
AUGUST 23, 2024
AstraZeneca says rumours that it will relocate a planned vaccines facility from the UK to the US "do not seem to be based on facts"
Pharmaceutical Commerce
AUGUST 23, 2024
The latest news for pharma industry insiders.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
AUGUST 23, 2024
Novartis and VC Versant set up a new biotech, Borealis Biosciences, using a similar model to an earlier alliance to create Chinook Therapeutics
Scott Burrows
AUGUST 23, 2024
Keynote Speaking C.W. Driver Annual Meeting at the Discovery Cube in Santa Ana, CA As I’ve talked to many, many leaders through the years, I’ve noticed many similar traits in work styles, life experiences, and mindsets. There was a time when I would have never labeled myself as a leader in any capacity. It wasn’t until I was forced to lead myself to success, that I saw traits of leadership in myself.
pharmaphorum
AUGUST 23, 2024
Zenas BioPharma has filed an initial public offering in the US seeking $100m+ for obexelimab, a therapy for rare disease IgG4-RD in phase 3
PharmaTimes
AUGUST 23, 2024
The conference will be held in Basel, Switzerland from 26-28 August
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
AUGUST 23, 2024
The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent months.Both new mRNA-based vaccines have been approved for use in people aged 12 and over – and been granted emergency use authorisation for younger people aged 6 months to 11 years – and will be available within the next few days, said the drugmakers.
Pharmaceutical Technology
AUGUST 23, 2024
The two companies have expanded their agreement first inked in 2023, with a second ‘high-value target’ now in the crosshairs.
pharmaphorum
AUGUST 23, 2024
ICER says Geron's new drug Rytelo for myelodysplastic syndromes (MDS) is priced three to four times higher than it should be
PharmaTimes
AUGUST 23, 2024
Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms
Pharmacy Times
AUGUST 23, 2024
The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.
Pharmaceutical Technology
AUGUST 23, 2024
The US FDA has approved and granted EUA for Moderna and Pfizer-BioNTech’s updated mRNA Covid-19 vaccines, Comirnaty and Spikevax.
Pharmacy Times
AUGUST 23, 2024
Bendamustine resulted in a greater risk of treatment complications in patients with lymphoma.
Pharmatutor
AUGUST 23, 2024
The New Penal Provisions in the Drugs and Cosmetics Act admin Sat, 08/24/2024 - 11:28 In a bid to decriminalise and rationalise offences to further enhance trust-based governance for ease of living and doing business, the Jan Vishwas (Amendment of Provisions) Act, 2023 was published in the Gazette of India, Extraordinary, Part II – Section 1, No. 21 on the 11th August, 2023.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
AUGUST 23, 2024
This designation follows the drug's rare pediatric disease designation in July 2024.
European Pharmaceutical Review
AUGUST 23, 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first treatment for Alzheimer’s in Great Britain that has shown some efficacy in slowing disease progression. Lecanemab is authorised to treat adults with early Alzheimer’s. It is therefore indicated for individuals with either one or no copies of the apolipoprotein E4 gene (ApoE4).
ALULA
AUGUST 23, 2024
What would happen if you applied some of the best and most modern practices for improving leadership performance in a sector that has traditionally shunned this kind of investment? That was the question being asked by executives at TD Bank’s Retail Card Services, who oversee the call centers through their Merchant Solutions and Customer Service operation.
PharmaTech
AUGUST 23, 2024
The collaboration builds on Novartis’ acquisition of Chinook Therapeutics just over a year ago.
Pharmaceutical Commerce
AUGUST 23, 2024
The updated COVID vaccine replaces previous bivalent vaccines, focusing on a single strain for more effective immunity.
PharmExec
AUGUST 23, 2024
64Cu-SAR-bisPSMA has demonstrated advantages over current diagnostic tools, such as higher tumor uptake, next-day imaging, and a longer half-life in PET imaging of PSMA-positive prostate cancer lesions, Clarity says.
Pharmaceutical Commerce
AUGUST 23, 2024
A prediction of how this shift toward patient-centric care may look.
Scott Burrows
AUGUST 23, 2024
In the dynamic world of franchising, where both challenges and opportunities abound, Scott Burrows stands out as a truly inspirational speaker. His remarkable journey from personal adversity to achieving success across various industries provides invaluable insights for franchisees and franchisors. With a proven track record of engaging with top franchises, Scott delivers impactful messages that resonate deeply within the franchise community.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
356 
Let's personalize your content